Pharmaceuticals
Healthcare
Lupin may raise up to $1.17B to prepare for acquisitions
Desh Bandhu Gupta-led drugmaker Lupin Ltd has obtained in-principle nod from its board for raising funds of up to Rs ......
Healthcare
Pharma company La Renon raises $16M from Sequoia
Ahmedabad-based pharmaceutical research, marketing and manufacturing company La Renon Healthcare Pvt Ltd has raised $16 million (Rs 100 crore) in ......
Healthcare
ChrysCap strikes exit from Mankind Pharma, to sell stake to Capital International
Private equity firm ChrysCapital has initiated the process to sell its entire stake in Mankind Pharma to global PE firm ......
Healthcare
Drug maker Alkem Laboratories picks three bankers for its mega IPO
Alkem Laboratories Ltd, a generic and specialty drug manufacturer which has been considering going public, has finalised its bankers for ......
Healthcare
Natco Pharma gets board nod to raise up to $71M
Hyderabad-based pharmaceutical firm Natco Ltd is planning to raise up to Rs 450 crore (approximately $70.7 million) through issuing shares ......
Healthcare
Cipla to acquire 51% stake in Ugandan firm Quality Chemicals for $30M
Mumbai-based drugmaker Cipla Ltd has agreed to acquire 51 per cent equity stake in Uganda-based Quality Chemicals Ltd (QCL) for ......
Healthcare
Strides Arcolab to buy Aspen's generic pharma business in Australia for $300M
Strides Arcolab Ltd has inked a deal to buy South African drugmaker Aspen Pharmacare's generic pharmaceutical business in Australia together ......
Healthcare
Lupin acquires Brazilian pharma company Medquímica Indústria
Mumbai-based pharma major Lupin Ltd has acquired Brazil-based pharma company Medquímica Indústria Farmacêutica S.A., Brazil, (Medquímica) for an undisclosed amount, ......
Healthcare
Torrent to buy dermatological formulations firm Zyg Pharma
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has signed a share purchase agreement to acquire Zyg Pharma Pvt Ltd, a company engaged ......
Healthcare
Mylan rejects Teva Pharma's $40B takeover offer
Generic drug-maker Mylan Inc's board has unanimously rejected the proposed $40 billion takeover bid by Israel-based Teva Pharmaceutical Industries Ltd, ......